```html

Yaws Bone Involvement – A Complete Patient‑Centred Guide

Overview

Yaws is a chronic, contagious skin disease caused by the spirochete bacterium Treponema pallidum subspecies pertenue. While most people think of yaws as a skin condition, the infection can progress to affect deeper structures, including bone and cartilage. This stage is known as **yaws bone involvement** or the “late (or tertiary) stage of yaws.”

Key points:

• Who it affects: Primarily children aged 5‑15 years living in rural, tropical, or subtropical areas with poor sanitation.
• Geographic distribution: Endemic in parts of West Africa, East Africa, South‑East Asia, the Pacific Islands, and some Central‑American communities. The World Health Organization (WHO) estimates that > 12 million people are at risk, with > 1 million active cases reported in the last decade.
• Prevalence of bone disease: Up to 10‑15 % of untreated or late‑stage yaws cases develop bone or joint involvement, most commonly at the tibia, femur, radius, and vertebrae (WHO, 2023).

Symptoms

Bone involvement appears months to years after the initial skin lesion. Symptoms can be subtle at first and may mimic other musculoskeletal disorders.

Typical clinical features

• Localized bone pain: Dull or throbbing pain, often worsening with activity and improving with rest.
• Swelling (edema) over affected bone: Soft‑tissue swelling may be visible, especially over the shins or wrists.
• Deformity: Chronic inflammation can lead to bowing of long bones (e.g., “genu valgum” – knock‑knees) or rounded shoulders.
• Limited range of motion: Joint involvement (especially at the knee, elbow, or wrist) can cause stiffness.
• Skin lesions: Persistent or recurrent papillomatous (wart‑like) lesions on the palms, soles, or other sites may coexist.
• Systemic signs: Low‑grade fever, malaise, or weight loss are uncommon but may occur during active infection.

Red‑flag symptoms that suggest more severe disease

• Sudden, severe pain that does not improve with analgesics.
• Rapidly increasing swelling, warmth, or redness (possible secondary bacterial infection).
• Neurological symptoms (numbness, tingling) suggesting nerve compression.
• Fever > 38.5 °C with chills.

Causes and Risk Factors

Cause

Yaws bone disease results from the spread of T. pallidum subsp. pertenue from the skin into the bloodstream, where the organism seeds the periosteum (the outer membrane of bone). Chronic inflammation leads to periostitis, osteitis, and ultimately bone remodeling.

Risk factors

• Age: Children 5‑15 years are the most vulnerable because of close contact in schools and play.
• Poverty & poor sanitation: Lack of clean water, inadequate footwear, and crowded living conditions increase transmission.
• Geographic isolation: Remote villages with limited access to health services delay diagnosis.
• Previous untreated yaws infection: Failure to receive appropriate antibiotics in the early stage dramatically raises the risk of late complications.
• Immunocompromising conditions: HIV infection or malnutrition can worsen disease progression.

Diagnosis

Diagnosing yaws bone involvement requires a combination of clinical suspicion, laboratory testing, and imaging.

Clinical assessment

• Detailed history of prior skin lesions, travel or residence in endemic regions, and exposure to infected individuals.
• Physical exam focusing on bone tenderness, swelling, and any active skin lesions.

Laboratory tests

• Serologic testing:
  • Rapid Plasma Reagin (RPR) or Venereal Disease Research Laboratory (VDRL) test – non‑treponemal, quantitative, used to monitor treatment response.
  • Treponemal tests (TPPA, FTA‑ABS) – confirm the presence of treponemal antibodies.
• Polymerase Chain Reaction (PCR): Detects T. pallidum DNA from skin swabs or bone biopsy specimens. Not widely available in low‑resource settings, but increasingly used in research and reference labs.
• Bone biopsy (rare): Histopathology shows granulomatous inflammation with spirochetes on special stains (Warthin‑Starry).

Imaging studies

• X‑ray: Classic findings include periosteal new bone formation (“onion‑skin” appearance), cortical thickening, and bone sclerosis.
• Ultrasound: Helpful for detecting soft‑tissue swelling and joint effusions, especially in children.
• Magnetic Resonance Imaging (MRI): Provides detailed visualization of bone marrow edema, periostitis, and adjacent soft‑tissue inflammation. Recommended when atypical features are present.

Diagnostic criteria (WHO recommendation)

A case of yaws bone involvement is confirmed when:

1. History or physical evidence of prior yaws infection.
2. Positive treponemal serology.
3. Radiographic changes consistent with periostitis/osteitis.
4. Absence of alternative diagnoses (e.g., tuberculosis, sickle‑cell disease).

Treatment Options

Early antibiotic therapy not only cures active skin disease but also halts progression of bone damage.

Antibiotic regimens

• Single‑dose oral azithromycin 30 mg/kg (max 2 g): Preferred by WHO for both early and late yaws because of oral administration, low side‑effect profile, and ease of mass‑treatment campaigns.
• Intramuscular benzathine penicillin G 2.4 million units: Alternative for patients who cannot receive azithromycin (e.g., allergy) or where azithromycin resistance is suspected.
• In cases of confirmed bone involvement, a **repeat dose** after 2–4 weeks is recommended to ensure eradication from deep tissues.

Adjunctive therapies

• Analgesics: Acetaminophen or ibuprofen for pain control.
• Physiotherapy: Gentle range‑of‑motion exercises to maintain joint flexibility and prevent contractures.
• Immobilization: Short‑term splinting for severely painful limbs; avoid prolonged casting to prevent joint stiffness.
• Nutritional support: Adequate protein, calcium, and vitamin D intake to promote bone healing.

Management of complications

If secondary bacterial infection of inflamed bone occurs, culture‑directed antibiotics (e.g., clindamycin or cefazolin) are added. In rare cases of extensive osteonecrosis, orthopedic surgery (debridement or corrective osteotomy) may be indicated.

Living with Yaws Bone Involvement

While the disease can be cured, residual bone changes may persist and affect daily life. The following practical tips help maintain function and comfort.

Daily management

• Footwear: Wear sturdy, closed shoes with good arch support to reduce stress on the tibia and ankle.
• Activity modification: Encourage low‑impact activities (swimming, cycling) while avoiding high‑impact running or jumping until pain subsides.
• Heat/cold therapy: Warm compresses can ease chronic pain; ice packs reduce swelling after activity.
• Pain diary: Track pain levels, triggers, and medication response to discuss with your clinician.
• Regular follow‑up: Repeat serology at 6 months and annually for 2 years to confirm cure.
• School & community support: Inform teachers about the condition so they can accommodate temporary activity restrictions.

Psychosocial considerations

Stigma surrounding skin lesions can affect self‑esteem. Community education programs that emphasize yaws is a bacterial infection, not a result of poor hygiene, help reduce discrimination.

Prevention

Because yaws is transmitted by direct skin‑to‑skin contact, public‑health measures focus on breaking the chain of infection.

• Mass drug administration (MDA): WHO recommends yearly oral azithromycin MDA in hyper‑endemic districts until < 5 % prevalence is achieved.
• Early case detection: Prompt treatment of primary lesions stops spread and prevents late complications.
• Personal hygiene: Regular washing of hands and feet, especially after playing outdoors.
• Protective clothing: Wearing shoes and long sleeves reduces skin abrasions that facilitate bacterial entry.
• Community education: School‑based health talks and visual aids increase awareness among children and parents.
• Surveillance: Local health workers should report new cases to national programs for rapid response.

Complications

If bone involvement is left untreated, several serious outcomes may arise.

• Permanent deformities: Bowing of long bones, limb length discrepancy, and joint contractures can affect mobility.
• Fracture risk: Osteopenic bone is more susceptible to fractures, especially in active children.
• Secondary infection: Ulcerated skin over bony prominences may develop bacterial cellulitis or osteomyelitis.
• Growth disturbance: Involvement of growth plates can impair normal bone growth, leading to stature loss.
• Functional impairment: Chronic pain and reduced range of motion may limit school attendance and participation in sports.

When to Seek Emergency Care

References

• World Health Organization. Yaws – Global eradication effort. 2023. WHO
• Mayo Clinic. Yaws disease. Updated 2022. Mayo Clinic
• Centers for Disease Control and Prevention. Treponemal diseases: Yaws. 2022. CDC
• National Institutes of Health. Treponema pallidum subspecies pertenue infection. 2021. NIH
• Cleveland Clinic. Bone pain – evaluation and management. 2023. Cleveland Clinic
• Johns Hopkins Medicine. Periostitis and osteitis in infectious diseases. 2020. Johns Hopkins

```